Example: confidence
Investor Update - roche.com

Investor Update - roche.com

Back to document page

final study results expected in second half of 2022 o Share purchase agreement with long-term partner TIB Molbiol to expand molecular diagnostics portfolio Outlook raised Sales CHF millions As % of sales % change January–September 2021 2021 2020 2021 2020 CER CHF Group sales 46,684 43,979 100.0 100.0 8 6 Pharmaceuticals

  Final, Roche

Download Investor Update - roche.com


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries